Add office photos
Employer?
Claim Account for FREE
Mayo Clinic
3.6
based on 4 Reviews
About Mayo Clinic
Founded in1889 (136 yrs old)
India Employee Count--
Global Employee Count50k-1 Lakh
HeadquartersRochester, Minnesota, United States (USA)
Office Locations
--
Websitemayoclinic.org
Primary Industry
Other Industries
--
Are you managing Mayo Clinic's employer brand? To edit company information,
claim this page for free
Mayo Clinic is the first and largest integrated, not-for-profit medical group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,800 physicians and scientists and 50,900 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn., Jacksonville, Fla., and Scottsdale/Phoenix, Ariz. Mayo Clinic also serves over 70 communities through Mayo Clinic Health System with locations in MN, IA, and WI. Collectively, these locations care for more than 1 million people each year
Mission: Mission To inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education and research. Primary value The needs of the patient come first. Value statements These values, which guide Mayo Clinic's mission to this day, are an expression of the vision and intent of our founders, the original Mayo physicians and the Sisters of Saint Francis. Respect Compassion Integrity Healing Teamwork Excellence Innovation Stewardship
Managing your company's employer brand?
Claim this Company Page for FREE
Mayo Clinic Ratings
based on 4 reviews
Overall Rating
3.5/5
How AmbitionBox ratings work?
5
2
4
0
3
1
2
0
1
1
Category Ratings
3.9
Work-life balance
3.8
Work satisfaction
3.6
Salary
3.6
Skill development
3.5
Company culture
3.5
Job security
3.5
Promotions
Mayo Clinic is rated 3.5 out of 5 stars on AmbitionBox, based on 4 company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Mayo Clinic Reviews
Compare Mayo Clinic with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.6/5 based on 4 reviews | 4.0/5 based on 2.6k reviews | 4.0/5 based on 1.4k reviews | 3.7/5 based on 2.7k reviews |
Highly Rated for | Work-life balance Work satisfaction | Job security Work-life balance Company culture | Skill development Work-life balance Salary | Job security |
Critically Rated for | No critically rated category | Promotions | Promotions | Promotions Salary |
Primary Work Policy | - | Hybrid 83% employees reported | Hybrid 55% employees reported | Work from office 53% employees reported |
Rating by Women Employees | - no rating available | 4.1 Good rated by 744 women | 3.8 Good rated by 229 women | 3.8 Good rated by 851 women |
Rating by Men Employees | - no rating available | 4.0 Good rated by 1.8k men | 4.1 Good rated by 1.1k men | 3.6 Good rated by 1.7k men |
Job security | 3.5 Good | 4.1 Good | 3.7 Good | 3.8 Good |
View more
Mayo Clinic Salaries
Mayo Clinic salaries have received with an average score of 3.6 out of 5 by 4 employees.
Cardiac Surgeon
(2 salaries)
Unlock
₹57 L/yr - ₹63 L/yr
Research Fellow
(2 salaries)
Unlock
₹3.6 L/yr - ₹4.6 L/yr
Administration Assistant
(1 salaries)
Unlock
₹2 L/yr - ₹2.6 L/yr
Junior Research Fellow
(1 salaries)
Unlock
₹0.5 L/yr - ₹0.6 L/yr
Post Doctoral Fellow
(1 salaries)
Unlock
₹0.9 L/yr - ₹1.2 L/yr
Research Assistant
(1 salaries)
Unlock
₹8.1 L/yr - ₹10.4 L/yr
Transplant Coordinator
(1 salaries)
Unlock
₹0.9 L/yr - ₹1.2 L/yr
Medical Officer
(1 salaries)
Unlock
₹9 L/yr - ₹11.5 L/yr
Gcp Data Engineer
(1 salaries)
Unlock
₹14.4 L/yr - ₹18.4 L/yr
Visiting Research Fellow
(1 salaries)
Unlock
₹21.6 L/yr - ₹27.6 L/yr
Mayo Clinic News
View all
Revolutionizing Heart Health: AI-Enhanced Mammograms Offer New Insights
- A groundbreaking study presented at the American College of Cardiology’s Annual Scientific Session reveals that AI-enhanced mammograms can not only detect cancer but also assess cardiovascular health by evaluating calcium buildup in breast arteries, showcasing the redefined role of mammograms in healthcare.
- Utilizing AI image analysis techniques, researchers have developed a method to quantify breast arterial calcifications on mammograms, translating findings into cardiovascular risk scores for patients, contributing significantly to preventive medicine.
- The presence of calcium in arteries serves as an early indicator of heart disease, with AI models effectively segmenting calcified structures in mammogram images and correlating the level of arterial calcification with potential cardiovascular outcomes over two- and five-year periods.
- Collaboration between Emory Healthcare and Mayo Clinic led to the development of this AI model, showing promising prospects for adoption in routine mammography screenings pending further validation and FDA clearance, potentially widening the diagnostic capabilities of mammograms.
- The study recommends expanding the use of mammograms beyond cancer detection to provide comprehensive insights into women's cardiovascular health, with the integration of AI in healthcare presenting opportunities for earlier detection and intervention, reshaping preventive frameworks.
- The study emphasizes the importance of harnessing advanced technologies like AI to enhance routine screenings, calling for a paradigm shift in healthcare towards a more holistic approach to women's health, particularly in addressing cardiovascular risks and improving patient outcomes.
- As these groundbreaking findings disseminate, healthcare providers are encouraged to leverage AI in mammography for dual cancer and cardiovascular screening, fostering collaboration and innovation in healthcare and prompting a shift towards comprehensive patient care through advanced medical technologies.
- The integration of AI into mammography represents a significant leap in preventive health strategies, offering the potential to revolutionize healthcare by enabling simultaneous screening for cancer and cardiovascular disease, ultimately leading to improved health outcomes and increased awareness of cardiovascular health among women.
- The evolving field of AI-assisted diagnosis and risk stratification in medical imaging holds promise for broader applications in healthcare, emphasizing the importance of ongoing research and clinical trials to validate these findings and enhance medical technologies for more integrated and effective healthcare systems.
Bioengineer | 20 Mar, 2025
Mayo Clinic Scientists Discover Key Genetic Mutation Linked to Metastasis and Survival Outcomes in Pancreatic Cancer
- Mayo Clinic scientists have identified a key genetic mutation, KRAS circulating tumor DNA (ctDNA), in pancreatic ductal adenocarcinoma (PDAC) that impacts cancer progression and patient outcomes.
- The detection of KRAS ctDNA through a blood test may revolutionize PDAC diagnostics by offering insights into metastasis and survival rates.
- Findings from a study involving nearly 800 patients revealed that those with the KRAS mutation had more advanced cancer stages and lower survival rates.
- Understanding a patient's KRAS status before surgery could lead to optimized treatment pathways, potentially improving surgical outcomes.
- The study underscores the importance of integrating advanced genetic testing like KRAS ctDNA into standard diagnostic protocols for PDAC.
- Mayo Clinic's initiative in championing this genetic test signifies a significant advancement in personalized patient care for PDAC.
- The research emphasizes the role of precision medicine in cancer care, with genomic testing becoming a standard for influencing treatment decisions and outcomes.
- Advancements in genetic testing tools offer hope to PDAC patients by enabling informed decision-making and potentially enhancing their quality of life.
- The study, published in the Annals of Surgical Oncology, points towards a future where genomic data integration in oncology practices is crucial for improved patient care.
- Overall, the study highlights the significance of genetic mutations like KRAS ctDNA in shaping treatment approaches and outcomes in pancreatic cancer.
Bioengineer | 20 Mar, 2025
Five benefits of a health tech accelerator program
- Health tech accelerator programs support startups in the health technology space by providing mentorship, funding, and networking opportunities.
- Access to experienced mentors and industry experts helps startups navigate complex health-care regulations and accelerate their growth.
- Accelerator programs offer seed funding, investment opportunities, and exposure to potential backers through demo days.
- Networking with key industry players in health care and technology ecosystems can help startups validate their products and gain credibility.
- Participating in prestigious accelerator programs can provide startups with market validation and legitimacy in a competitive market.
- Health tech accelerators often have connections to major health-care institutions, offering opportunities for pilots and proof of concept.
- Startups gain access to resources like clinical data, legal support, and technology infrastructure through accelerator programs.
- Health tech accelerator programs, such as Mayo Clinic Platform_Accelerate, help startups advance their solutions and bring them to market faster.
- Mayo Clinic Platform_Accelerate is a 30-week program offering access to clinical data, Mayo Clinic experts, investors, and technical resources.
- Accelerator programs play a key role in supporting health tech startups in overcoming challenges and transforming the health care industry.
TechnologyReview | 18 Mar, 2025
Breakthrough Research by Mayo Clinic Uncovers Proteins Associated with Immunotherapy Resistance in Metastatic Colorectal Cancer
- Mayo Clinic's research highlights the challenges of immunotherapy in treating metastatic colorectal cancer, emphasizing the need for predictive biomarkers to improve treatment outcomes.
- The study, published in Clinical Cancer Research, focuses on fibronectin and smooth muscle actin as potential biomarkers for patient stratification in immunotherapy.
- Utilizing advanced spatial profiling techniques, researchers examined protein expression in the tumor microenvironment, gaining insights into treatment resistance mechanisms.
- By analyzing the invasive margins of tumors, the researchers uncovered the role of fibronectin and smooth muscle actin in immunotherapy resistance.
- The study's findings emphasize the importance of personalized treatment strategies tailored to individual tumor characteristics and proteomic profiles.
- Discovering the impact of cancer-associated fibroblasts in producing resistance-related proteins signifies a shift in cancer treatment paradigms towards targeted interventions.
- This research signifies a crucial step towards refining immunotherapy regimens and overcoming resistance mechanisms present in metastatic colorectal cancer.
- The identification of fibronectin and smooth muscle actin as predictive markers for treatment resistance holds promise for enhancing patient outcomes and revolutionizing cancer care.
- As the field of immunotherapy advances, ongoing research into predictive biomarkers and personalized approaches is essential to improve therapeutic modalities for cancer patients.
- This study underscores the complexity of cancer biology and the potential for transformative advancements in oncology through a deeper understanding of tumor microenvironment interactions.
- Overall, this research sets the stage for a future where personalized treatments based on individual tumor characteristics offer new hope for improving outcomes in metastatic colorectal cancer.
Bioengineer | 14 Mar, 2025
City of Hope’s Phase 1 Clinical Trial Findings Featured in Society of Surgical Oncology Annual Meeting Press Program
- City of Hope's phase 1 clinical trial combines pressurized intraperitoneal aerosolized chemotherapy (PIPAC) with systemic chemotherapy, showing promise against metastatic colorectal and appendiceal cancers.
- Research addresses challenges in treating peritoneal cavity cancer, known for dire prognoses and limited survival rates, urging the need for innovative therapies like PIPAC for improved drug delivery.
- 19 participants with inoperable colorectal or appendiceal cancers involved in the trial had prior systemic chemotherapy with minimal success, prompting exploration of PIPAC's localized drug delivery method.
- PIPAC offers a finely aerosolized mist for deeper tissue penetration, enhancing chemotherapy effectiveness while minimizing systemic toxicity, potentially revolutionizing abdominal cavity chemotherapy delivery.
- Preliminary results suggest safety and clinical response, with evaluations based on histology, imaging, and tumor markers, indicating potential efficacy of PIPAC in treating peritoneal cancers.
- Dr. Mustafa Raoof underscores the need for larger trials to confirm long-term benefits and improved survival rates, cautioning against off-label PIPAC use until further evidence is gathered.
- City of Hope, pioneering PIPAC, aims to educate professionals and collaborate with institutions like Northwell Health and Mayo Clinic for broader acceptance and application of this innovative treatment.
- Dr. Raoof will present findings at the Society of Surgical Oncology Annual Meeting, highlighting the shift towards precision medicine in oncology and the potential of personalized cancer care.
- This trial signifies a significant step in cancer treatment innovation, emphasizing the continuous quest for new strategies to combat aggressive malignancies and improve patient outcomes.
- The research demonstrates the transformative impact of collaborative efforts and tailored therapies like PIPAC, signaling hope for enhanced cancer care and survival rates in the future.
Bioengineer | 12 Mar, 2025
Education, healthcare, skill development—How Gautam Adani is steering social transformation through a slew of initiatives
- Industrialist Gautam Adani's youngest son, Jeet Adani, made a Rs 10,000 crore donation pledge during his wedding ceremony.
- Gautam Adani, through the Adani Foundation, donated Rs 330 crore to improve access to education for disadvantaged communities and remote villages.
- Adani announced the launch of Adani Health City (AHC) in partnership with Mayo Clinic to provide affordable and accessible healthcare in Ahmedabad and Mumbai.
- The Adani Group has partnered with GEMS Education to establish schools across India, starting with Adani GEMS School of Excellence in Lucknow, offering affordable quality education.
- To address the skill gap crisis in India, the Adani Group will establish technical schools called Adani Global Skills Academy, in collaboration with ITE Education Services of Singapore.
Yourstory | 12 Mar, 2025
Mayo Clinic’s secret weapon against AI hallucinations: Reverse RAG in action
- Mayo Clinic has implemented a novel technique called reverse RAG to combat AI hallucinations in healthcare data.
- By employing backwards RAG, Mayo ensures that every data point links back to its original source content, reducing data-retrieval-based hallucinations.
- This technique has enabled Mayo to utilize AI more extensively in its clinical practice.
- Mayo initially applied AI in discharge summaries, where models excelled in extraction and summarization tasks.
- By avoiding hallucinations through careful building and verification, Mayo fine-tuned the AI models.
- Backwards RAG addresses limitations of RAG, such as irrelevant data retrieval, by using the CURE algorithm to double-check data extraction.
- The CURE technique's effectiveness also extends to synthesizing new patient records, saving practitioners significant time.
- Mayo sees potential in expanding AI capabilities to reduce administrative burden and assist physicians.
- Collaborations with companies like Cerebras Systems and Microsoft aim to enhance genomic modeling and imaging analysis for improved patient care.
- Mayo envisions using AI to personalize medicine by leveraging genomics and other 'omic' areas like proteomics to tailor treatments based on individual patient profiles.
- While AI holds promise in transforming patient care, rigorous validation and testing are essential in clinical settings for successful implementation.
VentureBeat | 7 Mar, 2025
Promising New Drug Offers Hope in Slowing Aortic Valve Disease Progression, Potentially Reducing Need for Surgeries
- Aortic valve stenosis (AVS) affects millions worldwide, necessitating surgical intervention for advanced cases.
- Mayo Clinic research focuses on ataciguat, a drug showing promise in slowing AVS progression.
- Ataciguat aims to address valvular calcification, a key factor in AVS development, potentially delaying surgeries.
- Preliminary studies highlight ataciguat's ability to impede AVS progression, prompting a phase 3 clinical trial.
- Ataciguat offers hope for delaying or preventing invasive treatments, enhancing patient quality of life.
- Younger patients with aggressive stenosis stand to benefit, potentially avoiding multiple surgeries in their lifetime.
- Mayo Clinic's research reveals ataciguat's effectiveness in halting AVS progression even after symptom onset.
- Phase 2 trials demonstrate ataciguat's tolerability and significant reduction in aortic valve calcification advancement.
- Collaborative efforts with academic and industry partners drive the advancement of ataciguat towards improved AVS management.
- Ataciguat represents a transformative potential in cardiovascular medicine, offering a non-surgical avenue for AVS treatment.
- Patient engagement and continued research investment play crucial roles in advancing cardiac therapeutics for AVS patients.
Bioengineer | 25 Feb, 2025
Mayo Clinic Researchers Uncover Promising New Immunotherapy Target for Ovarian Cancer
- Mayo Clinic researchers have identified cryptic antigens as a promising new immunotherapy target for ovarian cancer, published in Science Advances.
- Ovarian cancer poses challenges due to late-stage diagnoses and limited treatment efficacy from existing methods.
- The discovery focuses on previously overlooked cryptic antigens within tumors, offering a new approach to immunotherapy.
- Dr. Marion R. Curtis highlights the importance of activating T cells against these antigens for more effective therapies.
- Utilizing multi-omics approaches, researchers gained insights into tumor antigens and immune landscapes for tailored therapies.
- Cryptic antigens show promise as abundant T cell targets compared to neoantigens in ovarian cancer samples, prompting further investigation.
- Future steps involve preclinical testing and trials to evaluate immunotherapies targeting cryptic antigens across diverse tumor types.
- The study's implications extend beyond ovarian cancer, potentially revolutionizing cancer immunotherapy for various malignancies.
- This research challenges traditional treatment paradigms, paving the way for personalized precision medicine in oncology.
- Mayo Clinic's comprehensive approach in uncovering cryptic antigens sets a precedent for addressing challenging cancers and advancing medical science.
Bioengineer | 21 Feb, 2025
New proton beam therapy precisely targets and destroys cancer cells
- Mayo Clinic researchers pioneered a new therapy using proton beam radiation to target glioblastoma, a challenging form of brain cancer.
- Combining advanced imaging techniques with proton beam therapy allows for precise targeting of cancer cells while sparing healthy brain tissue.
- Patients received a short course of hypofractionated proton beam therapy over one to two weeks, along with chemotherapy.
- Results from the phase 2 trial showed promising outcomes, with a 56% survival rate at 12 months and a median survival of 13.1 months.
- Proton beam therapy proved beneficial for older patients, improving survival and quality of life compared to traditional treatments.
- The approach also reduced treatment duration and side effects, offering hope for glioblastoma patients.
- Mayo Clinic's ongoing SAGA trial aims to refine tumor visualization and treatment using advanced imaging techniques.
- The therapy's success stories, like Nadya El-Afandi, highlight the potential of this groundbreaking treatment for improving quality of life.
- Proton beam therapy shows promise in transforming glioblastoma treatment by making it more efficient and less burdensome for patients.
- The integration of advanced imaging with precision therapies marks a significant advancement in cancer treatment.
Brighter Side of News | 20 Feb, 2025
Powered by
Compare Mayo Clinic with
GE Healthcare
4.0
Baxter International
4.0
Philips Innovation Campus
3.8
Dishman Carbogen Amcis
3.7
Siemens Healthineers
4.0
B. Braun Medical
4.0
Ministry Of Health, New Delhi
4.3
Siemens Healthcare
4.3
Labcorp
4.1
Boston Scientific
4.0
PhyCARE Solutions
3.9
Arkray Healthcare
3.8
Quest Diagnostics
3.7
Biotech Vision Care
3.4
WebMD
3.6
International SOS
3.9
Life Care Hospital
3.9
Medical Billing Wholesalers
4.0
ResMed
3.7
Promantra Synergy Solutions
2.9
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Mayo Clinic
GeBBS Healthcare Solutions
Financial Services, Healthcare
3.7
• 2.7k reviews
UnitedHealth
Healthcare
4.0
• 2.6k reviews
Johnson & Johnson
Manufacturing, Healthcare
4.0
• 1.4k reviews
GE Healthcare
Healthcare
4.0
• 712 reviews
Baxter International
Medical Equipment, Healthcare, Pharma
4.0
• 655 reviews
Philips Innovation Campus
Consumer goods, Electronics, Analytics & KPO, Healthcare
3.8
• 507 reviews
Siemens Healthineers
Healthcare
4.0
• 427 reviews
B. Braun Medical
Healthcare
4.0
• 386 reviews
Ministry Of Health, New Delhi
Manufacturing, Metals & Mining, Healthcare
4.3
• 306 reviews
Siemens Healthcare
Manufacturing, Healthcare
4.3
• 294 reviews
Labcorp
Healthcare
4.1
• 287 reviews
Boston Scientific
Manufacturing, Healthcare
4.0
• 216 reviews
Mayo Clinic FAQs
When was Mayo Clinic founded?
Mayo Clinic was founded in 1889. The company has been operating for 136 years primarily in the Healthcare sector.
Where is the Mayo Clinic headquarters located?
Mayo Clinic is headquartered in Rochester, Minnesota.
What are the pros of working in Mayo Clinic?
Working at Mayo Clinic offers several advantages that make it an appealing place for employees. The company is highly rated for work life balance and work satisfaction, based on 4 employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
